PHASE I TRIAL OF ABRAXANE IN COMBINATION WITH GEMCITABINE IN SOLID TUMORS

ABRAXANE 联合吉西他滨治疗实体瘤的 I 期试验

• 批准号: 7625658
• 负责人: Thomas Stinchcombe
• 金额: $ 1.2万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7625658
• 关键词: Abraxane; Computer Retrieval of Information on Scientific Projects Database; Dose; Funding; Grant; Institution; Phase; Purpose; Research; Research Personnel; Resources; Solid Neoplasm; Source; Standards of Weights and Measures; Testing; United States National Institutes of Health; gemcitabine

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to see the highest amount of Abraxane that can be given with gemcitabine. Different doses of Abraxane will be tested. The amount of gemcitabine that is given will be the standard dose - different doses of gemcitabine are not being tested.

这个子项目是众多研究子项目之一